Multiple System Atrophy clinical trials
The registry lists 206 studies for Multiple System Atrophy across more than 10 countries. 73 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 89
- Recruiting
- 57
- Active, not recruiting
- 15
- Terminated
- 14
- Status unknown
- 11
- Not yet recruiting
- 9
Phase
- Phase 2
- 35
- Phase 1
- 21
- Phase 3
- 15
- Early Phase 1
- 13
- Phase 4
- 2
Where
- United States
- 90
- France
- 32
- China
- 26
- Italy
- 19
- United Kingdom
- 16
- Germany
- 13
Who runs them
Vanderbilt University Medical Center (10) · Vanderbilt University (9) · University Hospital, Bordeaux (9) · University Hospital, Toulouse (6) · NYU Langone Health (5) · Ruijin Hospital (4) · Alterity Therapeutics (4) · National Institute of Neurological Disorders and Stroke (NINDS) (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 206 — search for more.
- Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in FranceNot yet recruitingNCT07729852Phase 21 country
- Neurodegenerative Diseases RegistryRecruitingNCT044721301 country
- VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and ParkinsonismNot yet recruitingNCT078279631 country
- A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)Not yet recruitingNCT07825402Phase 3
- An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyRecruitingNCT07197866Phase 27 countries
- Expansion Study of ALT001 in Patients With Multiple System AtrophyRecruitingNCT07476352Early Phase 11 country
- The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar TypeRecruitingNCT07514923Early Phase 11 country
- Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)RecruitingNCT078059671 country
- Neurodegenerative Diseases Progression Markers (MARKERS-NDD)RecruitingNCT065967461 country
- A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSARecruitingNCT07604116Phase 11 country
- Autologous suraL nervE Grafting to the Substantia nigrA in Patients With SynuclienopathiesRecruitingNCT06683365Phase 11 country
- A Prospective Exploratory Study of the Safety and Preliminary Efficacy of the α-Syn H21 Monoclonal Antibody in Patients With Multiple System AtrophyNot yet recruitingNCT07774585Phase 11 country
- A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyRecruitingNCT06568237Phase 28 countries
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsRecruitingNCT04782830Not applicable1 country
- Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersRecruitingNCT07570212Not applicable1 country
- Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaRecruitingNCT076440131 country
- Natural History Study of SynucleinopathiesRecruitingNCT017999154 countries
- A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)RecruitingNCT06868628Phase 21 country
- Evaluation of [¹⁸F]MODAG-009 PET Imaging in SynucleinopathiesRecruitingNCT07640555Early Phase 11 country
- Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy VolunteersRecruitingNCT07617688Early Phase 11 country
- Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesNot yet recruitingNCT076048831 country
- Multiple System Atrophy Multidisciplinary ClinicRecruitingNCT038118081 country
- North American Prodromal Synucleinopathy Consortium Stage 2Enrolling by invitationNCT058264572 countries
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)RecruitingNCT04165486Phase 15 countries
- Comprehensive Swallowing Rehabilitation in Patients With MSARecruitingNCT04782284Not applicable1 country
- "An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."AvailableNCT072380621 country
- Pain and Autonomic Symptoms in Parkinson's Disease and Atypical ParkinsonismsRecruitingNCT057480281 country
- Post-Trial Access to ATH434 for Patients With Multiple System AtrophyAvailableNCT07531433
- Efficacy and Safety of Butylphthalide in the Treatment of Multiple System AtrophyNot yet recruitingNCT07518810Phase 2/31 country
- CPAP for the Treatment of Supine HypertensionRecruitingNCT05489575Not applicable1 country
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable1 country
- Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic DisordersRecruitingNCT07509125Not applicable1 country
- [18F]F-DOPA Imaging in Patients With Autonomic FailureRecruitingNCT04246437Phase 11 country
- Autologous Stem Cell Therapy in Patients With Multiple System AtrophyNot yet recruitingNCT07465198Phase 21 country
- Shanghai Clinical Cohort - Parkinson's Disease (Reserve)RecruitingNCT073534631 country
- MSA-01 in Multiple System AtrophyRecruitingNCT07446894Phase 31 country
- Synaptic Loss in Multiple System AtrophyRecruitingNCT051210121 country
- Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital BiomarkersRecruitingNCT073924111 country
- Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using NeuroimagingRecruitingNCT038721021 country
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionRecruitingNCT03042988Not applicable1 country
- Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical ActivityRecruitingNCT07324330Not applicable1 country
- The CurePSP Genetics ProgramRecruitingNCT066476411 country
- PET Imaging Evaluation of [11C]SY08RecruitingNCT06098612Early Phase 11 country
- [18F]ACI-15916 PET in α-synucleinopathiesRecruitingNCT06891703Early Phase 11 country
- Treatment of Supine Hypertension in Autonomic Failure (CPAP)RecruitingNCT03312556Not applicable1 country
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureRecruitingNCT02897063Phase 11 country
- AB-1005 Long-Term Follow-up StudyEnrolling by invitationNCT070818411 country
- The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System AtrophyRecruitingNCT06765733Early Phase 11 country
- Insulin Resistance in Multiple System AtrophyRecruitingNCT04250493Not applicable1 country
- hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative DiseasesNot yet recruitingNCT06607900Phase 11 country